2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in
Status
ACTIVE
Global HQ
Paris, France
Countries of investment
  • France
Investment stages
  • Seed
Industries
  • Health Tech
  • Biotechnology
About
Jeito Capital: A global biotech fund accelerating medical innovation with a patient benefit focus and societal impact. Empowering entrepreneurs to advance healthcare breakthroughs.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

Jeito Capital focuses on financing and accelerating groundbreaking medical innovation with the aim to build market leaders in their respective therapeutic areas, ensuring accelerated patient access globally.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Bringing over two decades of investment expertise, the fund manager has successfully completed more than 25 deals across technology and healthcare sectors, primarily in North America and Europe. With a thematic investment approach that emphasizes operator-first strategies, the manager has achieved several notable exits, enhancing portfolio performance. Leveraging data-driven insights, they focus on early to growth-stage companies, identifying transformative opportunities within dynamic markets. This diverse experience equips the manager with a robust framework for navigating complex investment landscapes.

Jeito Capital Contacts Information

Primary contact

Secondary contact

Team

Rafaèle Tordjman – Founder & CEO

Frédéric Degive – Partner

Marie-Morgane Colle – Partner

Edouard Vitry – Principal

Mikael Dolsten – Senior Advisor

Portfolio

Calliditas Therapeutics

Polares Medical

Neogene Therapeutics

Amolyt Pharma

SparingVision

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp